The middle cerebral artery is associated with contralateral hemiparesis and sensory loss, with the upper extremity being more affected than the lower. It also causes contralateral homonymous hemianopia and aphasia.

When a stroke occurs, the location of the lesion in the brain can determine the specific effects on the body. Depending on which artery is affected, different symptoms may arise. For example, a stroke in the anterior cerebral artery can lead to contralateral hemiparesis and sensory loss, with the lower extremity being more affected than the upper. On the other hand, a stroke in the middle cerebral artery can cause contralateral hemiparesis and sensory loss, with the upper extremity being more affected than the lower, as well as contralateral homonymous hemianopia and aphasia.

If the stroke occurs in the posterior cerebral artery, the individual may experience contralateral homonymous hemianopia with macular sparing and visual agnosia. In the case of Weber’s syndrome, which involves branches of the posterior cerebral artery that supply the midbrain, the person may have an ipsilateral CN III palsy and contralateral weakness of the upper and lower extremities.

Other types of strokes include those affecting the posterior inferior cerebellar artery, which can lead to ipsilateral facial pain and temperature loss and contralateral limb/torso pain and temperature loss, as well as ataxia and nystagmus. A stroke in the anterior inferior cerebellar artery can cause similar symptoms to Wallenberg’s syndrome, but with the addition of ipsilateral facial paralysis and deafness.

Finally, lacunar strokes are small, localized strokes that often occur in individuals with hypertension. They typically present with isolated hemiparesis, hemisensory loss, or hemiparesis with limb ataxia, and commonly affect the basal ganglia, thalamus, and internal capsule.

Although PEG tubes are linked to a considerable amount of morbidity, they are the most suitable choice for a long-term solution. A feeding jejunostomy necessitates the use of general anesthesia. TPN is not a viable alternative. Long-term nasogastric feeding is typically inadequate.

Enteral feeding is a method of providing nutrition to patients who are malnourished or at risk of malnutrition and have a functional gastrointestinal tract. It involves administering food directly into the stomach through a tube, which can be placed either through the nose (nasogastric tube) or directly into the stomach (gastrostomy tube). The type of tube used depends on the patient’s condition and the presence of upper gastrointestinal dysfunction.

To ensure safe and effective enteral feeding, healthcare professionals must check the placement of the tube using aspiration and pH tests. Gastric feeding is preferred, but if there is upper GI dysfunction, duodenal or jejunal tubes may be used. Patients in intensive care units (ICUs) should receive continuous feeding for 16-24 hours, and a motility agent may be used to aid gastric emptying. If this is ineffective, post-pyloric feeding or parenteral feeding may be considered.

Complications of enteral feeding include diarrhoea, aspiration, hyperglycaemia, and refeeding syndrome. Patients who are identified as malnourished or at risk of malnutrition should be considered for enteral feeding, especially if they have a BMI below 18.5 kg/m2, unintentional weight loss of more than 10% over 3-6 months, or a BMI below 20 kg/m2 and unintentional weight loss of more than 5% over 3-6 months. Surgical patients who are malnourished, have an unsafe swallow or inadequate oral intake, and have a functional GI tract may benefit from preoperative enteral feeding.

It is important to note that PEG tubes should not be removed until at least 2 weeks after insertion, and surgical patients due to have major abdominal surgery should be carefully evaluated before enteral feeding is initiated. Overall, enteral feeding is a valuable tool for providing nutrition to patients who are unable to eat normally, but it must be used with caution and under the guidance of a healthcare professional.

Understanding Cow’s Milk Protein Intolerance/Allergy

Cow’s milk protein intolerance/allergy (CMPI/CMPA) is a condition that affects around 3-6% of children, typically presenting in the first 3 months of life in formula-fed infants. Both immediate and delayed reactions can occur, with CMPA used for immediate reactions and CMPI for mild-moderate delayed reactions. Symptoms include regurgitation, vomiting, diarrhea, urticaria, atopic eczema, colic symptoms, wheeze, chronic cough, and rarely, angioedema and anaphylaxis. Diagnosis is often clinical, with investigations including skin prick/patch testing and total IgE and specific IgE (RAST) for cow’s milk protein.

Management for formula-fed infants includes using extensive hydrolyzed formula (eHF) milk as the first-line replacement formula for mild-moderate symptoms and amino acid-based formula (AAF) for severe CMPA or if no response to eHF. Around 10% of infants are also intolerant to soya milk. For breastfed infants, mothers should eliminate cow’s milk protein from their diet and consider prescribing calcium supplements to prevent deficiency. eHF milk can be used when breastfeeding stops until at least 6 months and up to 12 months of age.

The prognosis for CMPI is usually good, with most children becoming milk tolerant by the age of 3-5 years. However, a challenge is often performed in a hospital setting as anaphylaxis can occur. It is important to refer infants with severe symptoms to a pediatrician for management. Understanding CMPI/CMPA and its management can help parents and healthcare providers provide appropriate care for affected children.

Causes of Hypercalcaemia in Cancer Patients

Hypercalcaemia is a common occurrence in cancer patients, affecting around 10-20% of cases. It is caused by increased bone resorption and release of calcium from bone. The most common cancers associated with hypercalcaemia are breast and lung cancers, as well as multiple myeloma.

One of the most common causes of hypercalcaemia in patients with non-metastatic solid tumours is the secretion of parathyroid hormone-related peptide (PTHrP), also known as humoral hypercalcaemia of malignancy. This should be suspected in any patient with a solid tumour in the absence of bony metastases or in patients with unexplained hypercalcaemia and low serum PTH concentration. PTHrP is related in function to PTH and is most commonly secreted by breast and lung tumours.

Osteoclast-activating cytokines can also cause osteolytic metastases and release of calcium. Calcitonin is used to lower plasma calcium concentration in patients with hypercalcaemia associated with malignancy. Calcitriol is the cause of almost all cases of hypercalcaemia in Hodgkin’s disease and approximately one-third of cases in non-Hodgkin’s lymphoma. Secretion of PTH as a cause is rare, and serum PTH concentrations are typically low.

In conclusion, hypercalcaemia in cancer patients can have various causes, and it is important to identify the underlying cause to provide appropriate treatment.

Fallot’s Tetralogy

Fallot’s tetralogy is a congenital heart defect that consists of four features: ventricular septal defect, pulmonary stenosis, right ventricular hypertrophy, and an over-riding aorta. To diagnose this condition, doctors look for specific indicators. A step-down in oxygen saturation between the left atrium and left ventricle indicates a right to left shunt at the level of the ventricles, which is a sign of ventricular septal defect. Pulmonary stenosis is indicated by a significant gradient of 89 mmHg across the pulmonary valve, which is calculated by subtracting the right ventricular systolic pressure from the pulmonary artery systolic pressure. Right ventricular hypertrophy is diagnosed by high right ventricular pressures and a right to left shunt, as indicated by the oxygen saturations. Finally, an over-riding aorta is identified by a further step-down in oxygen saturation between the left ventricle and aorta. While this could also occur in cases of patent ductus arteriosus with right to left shunting, the presence of the other features of Fallot’s tetralogy makes an over-riding aorta the most likely cause of reduced oxygen saturation due to admixture of deoxygenated blood from the right ventricle entering the left heart circulation.

At day 5 of life, newborns undergo a heel prick test to check for various metabolic diseases including cystic fibrosis (CF), sickle cell disease, and congenital hypothyroidism. A positive result for CF is indicated by elevated levels of immunoreactive trypsinogen (IRT) and requires a sweat test to confirm the diagnosis. If the sweat test is also positive, the baby is diagnosed with CF.

Diagnosis of Cystic Fibrosis through Sweat Test

Cystic fibrosis (CF) is a genetic disorder that affects the respiratory, digestive, and reproductive systems. One of the most reliable ways to diagnose CF is through a sweat test. This test measures the amount of chloride in a patient’s sweat, which is abnormally high in those with CF. A normal value is less than 40 mEq/l, while a value greater than 60 mEq/l indicates CF.

However, there are some causes of false positive results, such as malnutrition, adrenal insufficiency, glycogen storage diseases, nephrogenic diabetes insipidus, hypothyroidism, hypoparathyroidism, G6PD, and ectodermal dysplasia. On the other hand, false negative results can occur due to skin edema, which is often caused by hypoalbuminemia or hypoproteinemia resulting from pancreatic exocrine insufficiency.

In conclusion, the sweat test is a reliable method for diagnosing CF, but it is important to consider the potential causes of false positive and false negative results. Proper interpretation of the test results can help ensure accurate diagnosis and appropriate treatment for patients with CF.

Reflux Nephropathy and its Management

Recurrent urinary tract infections during childhood are most likely caused by reflux nephropathy, which can lead to renal scarring, resistant hypertension, and chronic renal failure over time. Early intervention is crucial, including investigation in childhood, antibiotics, and referral to a urologist to identify and correct any anatomical abnormalities. Chronic interstitial nephritis caused by analgesic use is unlikely in this case, as the patient’s knee injury was likely acute. IgA nephropathy typically presents after respiratory tract infections, while post-streptococcal glomerulonephritis occurs 10-14 days after streptococcal pharyngitis. Essential hypertension is diagnosed based on the absence of an underlying cause. Proper management of reflux nephropathy can prevent long-term complications and improve the patient’s quality of life.

Differential Diagnosis for RUQ Pain: Acute Cholecystitis, Pancreatitis, Ascending Cholangitis, Gallstone Ileus, Biliary Colic

When a patient presents with right upper quadrant (RUQ) pain, it is important to consider several potential diagnoses. A positive Murphy’s sign, which is pain on deep palpation of the RUQ during inspiration, strongly suggests gallbladder involvement and makes acute cholecystitis the most likely diagnosis. Biliary colic is less likely as the patient is febrile, and ascending cholangitis is unlikely as the patient is not jaundiced. Pancreatitis is a possibility, but the pain is typically focused on the epigastrium and radiates to the back.

Gallstone ileus is a rare condition in which a gallstone causes obstruction in the small bowel. It would present with symptoms of obstruction, such as nausea, vomiting, and abdominal pain, with complete constipation appearing later. However, since this patient’s bowels last opened this morning, acute cholecystitis is a much more likely diagnosis.

It is important to consider all potential diagnoses and rule out other conditions, but in this case, acute cholecystitis is the most likely diagnosis. Treatment involves pain relief, IV antibiotics, and elective cholecystectomy.

This woman is displaying symptoms that are commonly associated with endometrial cancer, such as abdominal pain and bloating. She also has several risk factors for this type of cancer, including a history of PCOS, being nulliparous, and experiencing menopause after the age of 52. Other risk factors include obesity, endometrial hyperplasia, diabetes, tamoxifen, and unopposed estrogen. Interestingly, the risk associated with unopposed estrogen can be eliminated if progesterone is given concurrently.

While this woman has risk factors for breast cancer, her current symptoms are not indicative of this type of cancer. She does not have any risk factors for cervical cancer. It is important to note that abdominal pain and bloating are not normal symptoms of menopause. Normal menopausal symptoms include hot flashes, mood changes, musculoskeletal symptoms, vaginal dryness/itching, sexual dysfunction, and sleep disturbance.

Vaginal cancer typically presents with symptoms such as a vaginal mass, vaginal itching, discharge and pain, and vulval bleeding. Risk factors for this type of cancer include advancing age, infection with human papillomavirus, previous or current cervical cancer, smoking, and alcohol consumption.

Management of Tongue Tie in Infants: Referral for Frenotomy under No Anaesthesia

Tongue tie is a congenital condition that affects a baby’s ability to move their tongue due to a thickened frenulum. This can cause problems with breastfeeding and bottle feeding, leading to poor weight gain and irritability. In severe cases, a referral for frenotomy is necessary. In infants under three months of age, the procedure can be performed without anaesthesia, though local anaesthesia may be used. Conservative management and support with breastfeeding should be attempted first, but if unsuccessful, a frenotomy should be performed as early as possible to give the baby and mother the best chance at successful feeding. Frenotomy under general anaesthesia is only necessary for infants over three months of age. Converting to bottle feeding is not a solution in severe cases of tongue tie.

Lithium levels should be checked 12 hours after the last dose, ideally in the evening before bloods are taken the following morning. Taking the sample too soon or too late can lead to incorrect dosing adjustments.

Lithium is a medication used to stabilize mood in individuals with bipolar disorder and as an adjunct in treatment-resistant depression. It has a narrow therapeutic range of 0.4-1.0 mmol/L and is primarily excreted by the kidneys. The mechanism of action is not fully understood, but it is believed to interfere with inositol triphosphate and cAMP formation. Adverse effects may include nausea, vomiting, diarrhea, fine tremors, nephrotoxicity, thyroid enlargement, ECG changes, weight gain, idiopathic intracranial hypertension, leucocytosis, hyperparathyroidism, and hypercalcemia.

Monitoring of patients taking lithium is crucial to prevent adverse effects and ensure therapeutic levels. It is recommended to check lithium levels 12 hours after the last dose and weekly after starting or changing the dose until levels are stable. Once established, lithium levels should be checked every three months. Thyroid and renal function should be monitored every six months. Patients should be provided with an information booklet, alert card, and record book to ensure proper management of their medication. Inadequate monitoring of patients taking lithium is common, and guidelines have been issued to address this issue.

Osteoporosis is a condition that affects bone density and can lead to fractures. To diagnose osteoporosis, doctors use a DEXA scan, which measures bone mass. The results are compared to a young reference population, and a T score is calculated. A T score of -1.0 or higher is considered normal, while a score between -1.0 and -2.5 indicates osteopaenia, and a score below -2.5 indicates osteoporosis. The Z score is also calculated, taking into account age, gender, and ethnicity.

Electroconvulsive therapy is indicated for patients with treatment-resistant depression, as well as those experiencing manic episodes, moderate depression that has previously responded to ECT, and life-threatening catatonia. The Patient Health Questionnaire-9 (PHQ-9) is used by general practitioners to assess the severity of depression, with scores ranging from no depression to severe depression. However, the decision to pursue ECT is based on more than just the PHQ-9 score and requires a diagnosis of severe treatment-resistant depression.

Electroconvulsive therapy (ECT) is a viable treatment option for patients who suffer from severe depression that does not respond to medication, such as catatonia, or those who experience psychotic symptoms. The only absolute contraindication for ECT is when a patient has raised intracranial pressure.

Short-term side effects of ECT include headaches, nausea, short-term memory impairment, memory loss of events prior to the therapy, and cardiac arrhythmia. However, these side effects are typically temporary and resolve quickly.

Long-term side effects of ECT are less common, but some patients have reported impaired memory. It is important to note that the benefits of ECT often outweigh the potential risks, and it can be a life-changing treatment for those who have not found relief from other forms of therapy.

Appropriate Investigations for Iron Deficiency Anaemia in a Man

Iron deficiency anaemia in a man is often caused by chronic blood loss from the gastrointestinal tract. In this case, the patient’s altered bowel habits and lack of other symptoms suggest a colonic pathology, most likely a cancer. Therefore, a colonoscopy is the best investigation to identify the source of the bleeding.

A barium swallow is not appropriate in this case as it only examines the upper gastrointestinal tract. Abdominal angiography is an invasive and expensive test that is typically reserved for patients with massive blood loss or mesenteric ischaemia. While abdominal radiographs are useful, a colonoscopy is a more appropriate investigation in this case.

Upper gastrointestinal endoscopy is unlikely to reveal the cause of the patient’s symptoms as it primarily examines the upper gastrointestinal tract. However, it may be useful in cases of upper gastrointestinal bleeds causing melaena.

Urinalysis in Pregnancy: Common Abnormalities and Importance of Monitoring

Urinalysis is a crucial diagnostic tool for detecting renal diseases and other medical conditions. During pregnancy, even asymptomatic and healthy women may exhibit abnormalities on urinalysis. These abnormalities include small amounts of glucose, as pregnancy alters the renal threshold for glucose, and small amounts of protein, which can be a sign of pre-eclampsia. Ketones should not be present unless the patient is fasting, and prolonged fasting is not recommended. Pregnant women may also have sterile pyuria and non-specific changes in leukocytes.

It is important to monitor pregnant women for urinary infections, as they have been linked to premature labor. However, minor and non-specific changes on urinalysis can falsely reassure clinicians. Pregnant women are at an increased risk of UTIs and may present with atypical symptoms or unusual urinalysis features. Therefore, urine should be sent for culture if there are any concerns.

In summary, urinalysis is a vital investigation during pregnancy to detect abnormalities and monitor for urinary infections. Clinicians should be aware of the common abnormalities seen on urinalysis during pregnancy and the importance of careful monitoring to ensure the health of both the mother and the developing fetus.

Placenta praevia is characterized by painless and bright red bleeding, while placental abruption is accompanied by dark red bleeding and pain. The history of previous bleeding also suggests placenta praevia. Vasa praevia may also cause painless vaginal bleeding, but fetal bradycardia and membrane rupture are expected symptoms.

Understanding Placenta Praevia

Placenta praevia is a condition where the placenta is located wholly or partially in the lower uterine segment. It is a relatively rare condition, with only 5% of women having a low-lying placenta when scanned at 16-20 weeks gestation. However, the incidence at delivery is only 0.5%, as most placentas tend to rise away from the cervix.

There are several factors associated with placenta praevia, including multiparity, multiple pregnancy, and embryos implanting on a lower segment scar from a previous caesarean section. Clinical features of placenta praevia include shock in proportion to visible loss, no pain, a non-tender uterus, abnormal lie and presentation, and a usually normal fetal heart. Coagulation problems are rare, and small bleeds may occur before larger ones.

Diagnosis of placenta praevia should not involve digital vaginal examination before an ultrasound, as this may provoke severe haemorrhage. The condition is often picked up on routine 20-week abdominal ultrasounds, but the Royal College of Obstetricians and Gynaecologists recommends the use of transvaginal ultrasound for improved accuracy and safety. Placenta praevia is classified into four grades, with grade IV being the most severe, where the placenta completely covers the internal os.

In summary, placenta praevia is a rare condition that can have serious consequences if not diagnosed and managed appropriately. It is important for healthcare professionals to be aware of the associated factors and clinical features, and to use appropriate diagnostic methods for accurate grading and management.

Understanding Thyroid Disorders: Differentiating Poor Compliance with Thyroxine from Other Conditions

Thyroid disorders can present with a variety of symptoms, making it important to differentiate between different conditions. In the case of poor compliance with thyroxine medication, a patient may present with signs of a low thyroid state, but blood results will show a high TSH and normal T4, indicating recent medication use.

Primary hypothyroidism, on the other hand, would show a low T4 and high TSH, while thyrotoxicosis would reveal a low TSH and high T4, accompanied by symptoms such as tachycardia and tremors. Secondary hypothyroidism would present with low levels of both T4 and TSH, indicating a pituitary problem.

Sick euthyroid syndrome, which often occurs in individuals with systemic illness, would show low levels of TSH, thyroxine, and T3, but the TSH level may still be within the normal range. Understanding these differences can help healthcare professionals make accurate diagnoses and provide appropriate treatment.

Multiple Exostosis or Osteochondromas

Multiple exostosis or osteochondromas are typically seen in early adulthood, although they are believed to be congenital lesions that arise from displaced or abnormal growth plate cartilage. These growths may also occur in children with open growth plates who have been exposed to radiation. While spontaneous regression is rare, surgical removal is the preferred treatment option if necessary. Osteochondromas are most commonly found in the metaphysis of long bones, but they can also occur in any bone that develops through endochondral bone formation.

If pre-eclampsia is suspected in a woman, NICE recommends arranging emergency secondary care assessment. This is because pre-eclampsia can be asymptomatic and potentially life-threatening. In this case, the patient has high blood pressure (>=140/90 mmHg) and proteinuria (>= +1), which are features of pre-eclampsia. While a growth scan may be necessary as part of her overall management, it is not the priority at this time. Home BP monitoring is also not indicated now, as she needs further assessment first. Repeating the assessment in 24 hours is not appropriate, as emergency secondary care assessment is necessary. While labetalol may be used to manage her blood pressure, it should not be initiated before obstetric specialist investigation and input.

Pre-eclampsia is a condition that occurs during pregnancy and is characterized by high blood pressure, proteinuria, and edema. It can lead to complications such as eclampsia, neurological issues, fetal growth problems, liver involvement, and cardiac failure. Severe pre-eclampsia is marked by hypertension, proteinuria, headache, visual disturbances, and other symptoms. Risk factors for pre-eclampsia include hypertension in a previous pregnancy, chronic kidney disease, autoimmune disease, diabetes, chronic hypertension, first pregnancy, and age over 40. Aspirin may be recommended for women with high or moderate risk factors. Treatment involves emergency assessment, admission for observation, and medication such as labetalol, nifedipine, or hydralazine. Delivery of the baby is the most important step in management, with timing depending on the individual case.

If a patient has an ectopic pregnancy, the treatment plan will depend on various factors such as the size and location of the pregnancy, the patient’s overall health, and the potential impact on their fertility. If the pregnancy is small and the patient’s health is stable, they may be able to receive medication to dissolve the pregnancy. However, if the pregnancy is larger or causing severe symptoms, surgery may be necessary.

In cases where surgery is required, the surgeon may attempt to preserve the affected fallopian tube if possible. However, if the tube is severely damaged or the patient has other factors that may affect their fertility, such as age or previous fertility issues, the surgeon may opt to remove the tube completely. This decision will also depend on the patient’s desire for future fertility and the likelihood of requiring further treatment with methotrexate or a salpingectomy. If the patient’s contralateral tube is unaffected, complete removal of the affected tube may be the most appropriate course of action.

Ectopic pregnancy is a serious condition that requires prompt investigation and management. Women who are stable are typically investigated and managed in an early pregnancy assessment unit, while those who are unstable should be referred to the emergency department. The investigation of choice for ectopic pregnancy is a transvaginal ultrasound, which will confirm the presence of a positive pregnancy test.

There are three ways to manage ectopic pregnancies: expectant management, medical management, and surgical management. The choice of management will depend on various criteria, such as the size of the ectopic pregnancy, whether it is ruptured or not, and the patient’s symptoms and hCG levels. Expectant management involves closely monitoring the patient over 48 hours, while medical management involves giving the patient methotrexate and requires follow-up. Surgical management can involve salpingectomy or salpingostomy, depending on the patient’s risk factors for infertility.

Salpingectomy is the first-line treatment for women without other risk factors for infertility, while salpingostomy should be considered for women with contralateral tube damage. However, around 1 in 5 women who undergo a salpingostomy require further treatment, such as methotrexate and/or a salpingectomy. It is important to carefully consider the patient’s individual circumstances and make a decision that will provide the best possible outcome.